Advertisement

Reactions Weekly

, Volume 1209, Issue 1, pp 2–2 | Cite as

... and stronger warnings for etoricoxib

Media release
  • 9 Downloads

Keywords

Public Health Hypertension Rheumatoid Arthritis Arthritis Ankylose Spondylitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    European Medicines Agency (EMEA).EMEA recommends strengthening warnings and contraindications for etoricoxib-containing medicines used in the treatment of rheumatoid arthritis and ankylosing spondylitis. Media Release: 26 Jun 2008. Available from: URL: http://www.emea.europe.eu

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations